AdaptHealth posts Q3 loss due to goodwill impairment charge
AHCO•AdaptHealth reported a third-quarter net loss of $152.77 million, including a $184.8 million goodwill impairment, as revenue rose 10.9% to $745.65 million. It raised its 2026 revenue and adjusted EBITDA outlook but lowered its free cash flow forecast.
1. Quarterly results
AdaptHealth reported a third-quarter net loss of $152.77 million and a loss per share of $1.13, including a $184.8 million goodwill impairment charge. Revenue increased 10.9% year over year to $745.65 million, slightly below the $746.45 million consensus estimate, while adjusted EBITDA fell 2.9% year over year.
2. 2026 outlook
The company raised its 2026 net revenue guidance to $2.88 billion-$2.90 billion from $2.85 billion-$2.89 billion, and lifted its adjusted EBITDA outlook to $510 million-$525 million from $490 million-$520 million. It lowered its free cash flow forecast to $50 million-$75 million from $80 million-$120 million.
3. Business drivers
AdaptHealth said an exclusive capitated agreement with a national integrated delivery network improved contract profitability through lower labor costs. It reported organic revenue growth across its Sleep Health, Respiratory Health and Wellness at Home segments, and said the pending sale of its Diabetes Health business will allow greater focus on its core segments.
